Proteomics of vitamin B 12 processing

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 3, 2013, Pages 477-488

  Hannibal, Luciana ^c   Dibello, Patricia M ^a   Jacobsen, Donald W ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

CblC; Cobalamin deficiency; Cobalamin processing; Homocysteine; Methylmalonic acid; MMACHC (methylmalonic aciduria type C with homocystinuria)

Indexed keywords

BIOLOGICAL MARKER; COBALAMIN; CYANOCOBALAMIN; HYDROXOCOBALAMIN; CARRIER PROTEIN; CYTOSKELETON PROTEIN; MMACHC PROTEIN, HUMAN;

CONFERENCE PAPER; CYANOCOBALAMIN DEFICIENCY; CYTOSKELETON; DETOXIFICATION; DIETARY INTAKE; FAILURE TO THRIVE; GENE CONTROL; HYPERHOMOCYSTEINEMIA; INTRACELLULAR TRANSPORT; MEGALOBLASTIC ANEMIA; METHYLMALONIC ACIDEMIA; NERVOUS SYSTEM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FOLDING; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PROTEOMICS; SIGNAL TRANSDUCTION; CHEMISTRY; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PATHOLOGY; REVIEW;

CARRIER PROTEINS; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION; HUMANS; NERVOUS SYSTEM; PROTEIN BIOSYNTHESIS; PROTEOMICS; SIGNAL TRANSDUCTION; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 84882375179     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0568     Document Type: Conference Paper

References (107)

1. 12-binding domains of methionine synthase. Science 1994;266:1669-74.
2. 12: the beautiful molecule. Cleve Clin Mag 2010;7:20-6.
3. 12-processing enzyme. J Biol Chem 2011;286:29780-7.
4. 12. Appl Microbiol Biotechnol 2002;58:275-85.
5. Okada K, Tanaka H, Temporin K, Okamoto M, Kuroda Y, Moritomo H, et al. Akt/mammalian target of rapamycin signaling pathway regulates neurite outgrowth in cerebellar granule neurons stimulated by methylcobalamin. Neurosci Lett 2011;495:201-4.
6. Jorge-Finnigan A, Gamez A, Perez B, Ugarte M, Richard E. Different altered pattern expression of genes related to apoptosis in isolated methylmalonic aciduria cblB type and combined with homocystinuria cblC type. Biochim Biophys Acta 2010;1802:959-67.
7. Richard E, Alvarez-Barrientos A, Perez B, Desviat LR, Ugarte M. Methylmalonic acidaemia leads to increased production of reactive oxygen species and induction of apoptosis through the mitochondrial/caspase pathway. J Pathol 2007;213:453-61.
8. Orozco-Barrios CE, Battaglia-Hsu SF, Arango-Rodriguez ML, Ayala-Davila J, Chery C, Alberto JM, et al. Vitamin B 12-impaired metabolism produces apoptosis and Parkinson phenotype in rats expressing the transcobalamin-oleosin chimera in substantia nigra. PLoS One 2009;4:e8268.
9. Richard E, Jorge-Finnigan A, Garcia-Villoria J, Merinero B, Desviat LR, Gort L, et al. Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC). Hum Mutat 2009;30:1558-66.
10. Scalabrino G. The multi-faceted basis of vitamin B 12 (cobalamin) neurotrophism in adult central nervous system: lessons learned from its deficiency. Prog Neurobiol 2009;88:203-20.
11. Scalabrino G. Vitamin-regulated cytokines and growth factors in the CNS and elsewhere. J Neurochem 2009;111:1309-26.
12. Quadros EV, Nakayama Y, Sequeira JM. The protein and the gene encoding the receptor for the cellular uptake of transcobalaminbound cobalamin. Blood 2009;113:186-92.
13. Amagasaki T, Green R, Jacobsen DW. Expression of transcobalamin II receptors by human leukemia K562 and HL-60 cells. Blood 1990;76:1380-6.
14. 12: a new complementation group causing methylmalonic aciduria (cblF). Am J Hum Genet 1986;39:404-8.
15. 12 (cb1F): a hereditary cobalamin metabolic disorder associated with sudden death. Am J Med Genet 1989;33:555-63.
16. Vassiliadis A, Rosenblatt DS, Cooper BA, Bergeron JJ. Lysosomal cobalamin accumulation in fibroblasts from a patient with an inborn error of cobalamin metabolism (cblF complementation group): visualization by electron microscope radioautography. Exp Cell Res 1991;195:295-302.
17. Laframboise R, Cooper BA, Rosenblatt DS. Malabsorption of vitamin B 12 from the intestine in a child with cblF disease: evidence for lysosomal-mediated absorption. Blood 1992;80:291-2.
18. Waggoner DJ, Ueda K, Mantia C, Dowton SB. Methylmalonic aciduria (cblF): case report and response to therapy. Am J Med Genet 1998;79:373-5.
19. 12 metabolism. Nat Genet 2009;41:234-9.
20. Oladipo O, Rosenblatt DS, Watkins D, Miousse IR, Sprietsma L, Dietzen DJ, et al. Cobalamin F disease detected by newborn screening and follow-up on a 14-year-old patient. Pediatrics 2011;128:e1636-40.
21. 12 metabolism. Mol Genet Metab 2011;102:505-7.
22. Coelho D, Kim JC, Miousse IR, Fung S, Du Moulin M, Buers I, et al. Mutations in ABCD4 cause a new inborn error of vitamin B 12 metabolism. Nat Genet 2012;44:1152-5.
23. Watkins D, Rosenblatt DS. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet 2011;157:33-44.
24. Froese DS, Gravel RA. Genetic disorders of vitamin B 12 metabolism: eight complementation groups - eight genes. Expert Rev Mol Med 2010;12:e37.
25. Chu RC, Begley JA, Colligan PD, Hall CA. The methylcobalamin metabolism of cultured human fibroblasts. Metabolism 1993;42:315-9.
26. Mudd SH, Levy HL, Abeles RH. A derangment in B 12 metabolism leading to homocystinemia, cystathioninemia and methylmalonic aciduria. Biochem Biophys Res Commun 1969;35:121-6.
27. Lerner-Ellis JP, Anastasio N, Liu J, Coelho D, Suormala T, Stucki M, et al. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. Hum Mutat 2009;30:1072-81.
28. Pezacka EH, Denison CJ, Green R, Jacobsen DW. Biosynthesis of methylcobalamin: chemical model studies with thiol-cobalamin adducts and S-adenosylmethionine. J Cell Physiol 1988;107:860a.
29. Pezacka E, Green R, Jacobsen DW. Glutathionylcobalamin as an intermediate in the formation of cobalamin coenzymes. Biochem Biophys Res Commun 1990;169:443-50.
30. Pezacka EH, Green R, Jacobsen DW. Intracellular cobalamin metabolism: a thiol-cobalamin adduct as an intermediate in cobalamin coenzyme formation. FASEB J 1990;4:A2126.
31. Pezacka EH. Identification and characterization of two enzymes involved in the intracellular metabolism of cobalamin. Cyanocobalamin beta-ligand transferase and microsomal cob (III) alamin reductase. Biochim Biophys Acta 1993;1157:167-77.
32. Pezacka EH, Rosenblatt DS. Intracellular metabolism of cobalamin. Altered activities of B-axial-ligand transferase and microsomal cob (III) alamin reductase in cbl C and cbl D fibroblasts. In: Bhatt, James, Besser, Bottazzo, Keen, editors. Advances in Thomas Addison's Diseases. Bristol: J. Endocrinol. Ltd., 1994:315-23.
33. 12 trafficking in mammals: a for coenzyme escort service. ACS Chem Biol 2006;1:149-59.
34. Lerner-Ellis JP, Tirone JC, Pawelek PD, Dore C, Atkinson JL, Watkins D, et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat Genet 2006;38:93-100.
35. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008;134:112-23.
36. Kim J, Gherasim C, Banerjee R. Decyanation of vitamin B 12 by a trafficking chaperone. Proc Natl Acad Sci USA 2008;105:14551-4.
37. Hannibal L, Kim J, Brasch NE, Wang S, Rosenblatt DS, Banerjee R, et al. Processing of alkylcobalamins in mammalian cells: a role for the MMACHC (cblC) gene product. Mol Genet Metab 2009;97:260-6.
38. 12trafficking protein uses glutathione transferase activity for processing alkylcobalamins. J Biol Chem 2009;284:33418-24.
39. 12-responsive cblC disorder. Mol Genet Metab 2010;100:29-36.
40. 12-responsiveness in cblC methylmalonic aciduria with homocystinuria. Mol Genet Metab 2009;98:338-43.
41. Park J, Jeong J, Kim J. Destabilization of a bovine B 12 trafficking chaperone protein by oxidized form of glutathione. Biochem Biophys Res Commun 2012;420:547-51.
42. 12 trafficking chaperone bCblC for vitamin B 12. Biochem Biophys Res Commun 2011;412:360-5.
43. 12 trafficking chaperone. BMB Rep 2011;44:170-5.
44. 12trafficking chaperone protein. Protein J 2012;31:158-65.
45. 12 processing function. Biochemistry 2012;51:5083-90.
46. Coelho D, Suormala T, Stucki M, Lerner-Ellis JP, Rosenblatt DS, Newbold RF, et al. Gene identification for the cblD defect of vitamin B 12 metabolism. N Engl J Med 2008;358:1454-64.
47. Miousse IR, Watkins D, Coelho D, Rupar T, Crombez EA, Vilain E, et al. Clinical and molecular heterogeneity in patients with the cblD inborn error of cobalamin metabolism. J Pediatr 2009;154:551-6.
48. Stucki M, Coelho D, Suormala T, Burda P, Fowler B, Baumgartner MR. Molecular mechanisms leading to three different phenotypes in the cblD defect of intracellular cobalamin metabolism. Hum Mol Genet 2012;21:1410-8.
49. 12 metabolism. Mol Genet Metab 2011;102:139-48.
50. 12 metabolism. Mol Genet Metab 2012;107:352-62.
51. Hannibal L, Di Bello PM, Yu M, Miller A, Wang S, Willard B, et al. The MMACHC proteome: hallmarks of functional cobalamin deficiency in humans. Mol Genet Metab 2011;103:226-39.
52. Adams D, Venditti CP. Disorders of intracellular cobalamin metabolism. GeneReviews TM 2009. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. Seattle (WA): University of Washington, Seattle, 2008.
53. Morel CF, Lerner-Ellis JP, Rosenblatt DS. Combined methylmalonic aciduria and homocystinuria (cblC): phenotypegenotype correlations and ethnic-specific observations. Mol Genet Metab 2006;88:315-21.
54. Ben-Omran TI, Wong H, Blaser S, Feigenbaum A. Late-onset cobalamin-C disorder: a challenging diagnosis. Am J Med Genet A 2007;143A:979-84.
55. Heil SG, Hogeveen M, Kluijtmans LA, Van Dijken PJ, Van De Berg GB, Blom HJ, et al. Marfanoid features in a child with combined methylmalonic aciduria and homocystinuria (CblC type). J Inherit Metab Dis 2007;30:811.
56. Sharma AP, Greenberg CR, Prasad AN, Prasad C. Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder. Pediatr Nephrol 2007;22:2097-103.
57. Gerth C, Morel CF, Feigenbaum A, Levin AV. Ocular phenotype in patients with methylmalonic aciduria and homocystinuria, cobalamin C type. J AAPOS 2008;12:591-6.
58. Thauvin-Robinet C, Roze E, Couvreur G, Horellou MH, Sedel F, Grabli D, et al. The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum. J Neurol Neurosurg Psychiatry 2008;79:725-8.
59. 12chaperone MMACHC can result in increased tumorigenicity and methionine dependence. Mol Genet Metab 2009;96:261-7.
60. Tang H, Hao H, Tang SH, Chen X, Liu F, Cha QB, et al. [Mutation analysis of the MMACHC gene in a pedigree with methylmalonic aciduria]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2009;26:62-5.
61. Wang F, Han LS, Hu YH, Yang YL, Ye J, Qiu WJ, et al. [Analysis of gene mutations in Chinese patients with methylmalonic acidemia and homocysteinemia]. Zhonghua Er Ke Za Zhi 2009;47:189-93.
62. Brunel-Guitton C, Costa T, Mitchell GA, Lambert M. Treatment of cobalamin C (cblC) deficiency during pregnancy. J Inherit Metab Dis Epub 2010 Sep. 10. DOI: 10.1007/s10545-010-9202-7.
63. Frattini D, Fusco C, Ucchino V, Tavazzi B, Della Giustina E. Early onset methylmalonic aciduria and homocystinuria cblC type with demyelinating neuropathy. Pediatr Neurol 2010;43:135-8.
64. Wang F, Han L, Yang Y, Gu X, Ye J, Qiu W, et al. Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China. J Inherit Metab Dis Epub 2010 Oct. 6. DOI: 10.1007/s10545-010-9217-0.
65. Weisfeld-Adams JD, Morrissey MA, Kirmse BM, Salveson BR, Wasserstein MP, McGuire PJ, et al. Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. Mol Genet Metab 2010;99:116-23.
66. Chang JT, Chen YY, Liu TT, Liu MY, Chiu PC. Combined methylmalonic aciduria and homocystinuria cblC type of a Taiwanese infant with c.609G > A and C.567dupT mutations in the MMACHC gene. Pediatr Neonatol 2011;52:223-6.
67. Martinelli D, Deodato F, Dionisi-Vici C. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis 2011;34:127-35.
68. Pupavac M, Garcia MA, Rosenblatt DS, Jerome-Majewska LA. Expression of MMACHC and MMADHC during mouse organogenesis. Mol Genet Metab 2011;103:401-5.
69. Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis 2012;35:91-102.
70. Menni F, Testa S, Guez S, Chiarelli G, Alberti L, Esposito S. Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria. Pediatr Nephrol 2012;27:1401-5.
71. Wang X, Sun W, Yang Y, Jia J, Li C. A clinical and gene analysis of late-onset combined methylmalonic aciduria and homocystinuria, cblC type, in China. J Neurol Sci 2012;318:155-9.
72. Experience the power of 2-D electrophoresis with 2-D DIGE. GE Healthcare Life Sciences, 2012. Available from: https://www.gelifesciences.com/gehcls- images/GELS/Related%20Content/Files/1347435454111/litdoc11001340AE- 20120914132155.pdf. Accessed October, 2012.
73. Suormala T, Baumgartner MR, Coelho D, Zavadakova P, Kozich V, Koch HG, et al. The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis. J Biol Chem 2004;279:42742-9.
74. Richard E, Monteoliva L, Juarez S, Perez B, Desviat LR, Ugarte M, et al. Quantitative analysis of mitochondrial protein expression in methylmalonic acidemia by two-dimensional difference gel electrophoresis. J Proteome Res 2006;5:1602-10.
75. Katula KS, Heinloth AN, Paules RS. Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix. J Nutr Biochem 2007;18:541-52.
76. Duthie SJ, Mavrommatis Y, Rucklidge G, Reid M, Duncan G, Moyer MP, et al. The response of human colonocytes to folate deficiency in vitro: functional and proteomic analyses. J Proteome Res 2008;7:3254-66.
77. Jimenez-Mallebrera C, Maioli MA, Kim J, Brown SC, Feng L, Lampe AK, et al. A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations. Neuromuscul Disord 2006;16:571-82.
78. Kanagawa M, Toda T. The genetic and molecular basis of muscular dystrophy: roles of cell-matrix linkage in the pathogenesis. J Hum Genet 2006;51:915-26.
79. Majors AK, Sengupta S, Jacobsen DW, Pyeritz RE. Upregulation of smooth muscle cell collagen production by homocysteineinsight into the pathogenesis of homocystinuria. Mol Genet Metab 2002;76:92-9.
80. Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease - enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2074-81.
81. Mor-Vaknin N, Punturieri A, Sitwala K, Markovitz DM. Vimentin is secreted by activated macrophages. Nat Cell Biol 2003;5:59-63.
82. Yoshio T, Morita T, Kimura Y, Tsujii M, Hayashi N, Sobue K. Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation. FEBS Lett 2007;581:3777-82.
83. Lin CS, Park T, Chen ZP, Leavitt J. Human plastin genes. Comparative gene structure, chromosome location, and differential expression in normal and neoplastic cells. J Biol Chem 1993;268:2781-92.
84. Oprea GE, Krober S, McWhorter ML, Rossoll W, Muller S, Krawczak M, et al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 2008;320:524-7.
85. Gong B, Leznik E. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders. Drug News Perspect 2007;20:365-70.
86. Wilson PO, Barber PC, Hamid QA, Power BF, Dhillon AP, Rode J, et al. The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol 1988;69:91-104.
87. Doran JF, Jackson P, Kynoch PA, Thompson RJ. Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J Neurochem 1983;40:1542-7.
88. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 2002;82:1524-32.
89. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, et al. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 2004;279:13256-64.
90. Butterfield DA, Gnjec A, Poon HF, Castegna A, Pierce WM, Klein JB, et al. Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: an initial assessment. J Alzheimers Dis 2006;10:391-7.
91. Andersson HC, Marble M, Shapira E. Long-term outcome in treated combined methylmalonic acidemia and homocystinemia. Genet Med 1999;1:146-50.
92. Abou-Sleiman PM, Healy DG, Quinn N, Lees AJ, Wood NW. The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann Neurol 2003;54:283-6.
93. Annesi G, Savettieri G, Pugliese P, D'Amelio M, Tarantino P, Ragonese P, et al. DJ-1 mutations and parkinsonismdementia-amyotrophic lateral sclerosis complex. Ann Neurol 2005;58:803-7.
94. Kitamura K, Takayama M, Hamajima N, Nakanishi M, Sasaki M, Endo Y, et al. Characterization of the human dihydropyrimidinaserelated protein 2 (DRP-2) gene. DNA Res 1999;6:291-7.
95. Ito H, Iwamoto I, Morishita R, Nozawa Y, Narumiya S, Asano T, et al. Possible role of Rho/Rhotekin signaling in mammalian septin organization. Oncogene 2005;24:7064-72.
96. Appenzeller-Herzog C, Ellgaard L. The human PDI family: versatility packed into a single fold. Biochim Biophys Acta 2008;1783:535-48.
97. Gregersen N. Protein misfolding disorders: pathogenesis and intervention. J Inherit Metab Dis 2006;29:456-70.
98. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calciumand phospholipid-binding proteins. Biochim Biophys Acta 1994;1197:63-93.
99. 2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005;6:449-61.
100. Grewal T, Enrich C. Molecular mechanisms involved in Ras inactivation: the annexin A6-p120GAP complex. Bioessays 2006;28:1211-20.
101. Stevens TH, Forgac M. Structure, function and regulation of the vacuolar (H +)-ATPase. Annu Rev Cell Dev Biol 1997;13:779-808.
102. Meins T, Vonrhein C, Zeth K. Crystallization and preliminary X-ray crystallographic studies of human voltage-dependent anion channel isoform I (HVDAC1). Acta Crystallogr Sect F Struct Biol Cryst Commun 2008;64:651-5.
103. Hiller S, Garces RG, Malia TJ, Orekhov VY, Colombini M, Wagner G. Solution structure of the integral human membrane protein VDAC-1 in detergent micelles. Science 2008;321:1206-10.
104. Takeshita H, Fujihara J, Takastuka H, Agusa T, Yasuda T, Kunito T. Diversity of glutathione s-transferase omega 1 (a140d) and 2 (n142d) gene polymorphisms in worldwide populations. Clin Exp Pharmacol Physiol 2009;36:283-6.
105. Inskip A, Elexperu-Camiruaga J, Buxton N, Dias PS, MacIntosh J, Campbell D, et al. Identif cation of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J 1995;312:713-6.
106. Campbell E, Takahashi Y, Abramovitz M, Peretz M, Listowsky I. A distinct human testis and brain mu-class glutathione S-transferase. Molecular cloning and characterization of a form present even in individuals lacking hepatic type mu isoenzymes. J Biol Chem 1990;265:9188-93.
107. Gong B, Cao Z, Zheng P, Vitolo OV, Liu S, Staniszewski A, et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 2006;126:775-88.